Karlsen, Tom H.
Oslo University Hospital · University of Oslo
40 papers on CoChatORCID 0000-0002-8289-9931
Most cited papers
- Verified
Liver transplantation in the Nordic countries - an intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013
Fosby, B., Melum, E., Bjøro, K., Bennet, W., Rasmussen, A., Andersen, I. M., Castedal, M., Olausson, M., Wibeck, C., Gotlieb, M., et al. (2015) · Scandinavian Journal of Gastroenterology
Organ Transplantation Techniques and OutcomesTransplantation: Methods and Outcomes
Cited by 99
- Verified
FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis
Wannhoff, A., Hov, J. R., Folseraas, T., Rupp, C., Friedrich, K., Anmarkrud, J. A., Weiss, K. H., Sauer, P., Schirmacher, P., Boberg, K. M., et al. (2013) · Journal of Hepatology
Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and Immunity
Cited by 94
- Verified
Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis
Lei, L., Bruneau, A., El Mourabit, H., Guégan, J., Folseraas, T., Lemoinne, S., Karlsen, T. H., Hoareau, B., Morichon, R., Gonzalez‐Sanchez, E., et al. (2022) · Hepatology
Liver physiology and pathologyLiver Disease Diagnosis and Treatment
Cited by 94
- Verified
Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis
Chung, B. K., Øgaard, J., Reims, H. M., Karlsen, T. H., & Melum, E. (2022) · Hepatology Communications
Single-cell and spatial transcriptomicsLiver physiology and pathology
Cited by 85
- Verified
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International
Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment
Cited by 83
- Verified
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Jendrek, S. T., Gotthardt, D., Nitzsche, T., Widmann, L., Korf, T., Michaels, M. A., Weiss, K.-H., Liaskou, E., Vesterhus, M., Karlsen, T. H., et al. (2017) · Gut
Liver Diseases and ImmunityInflammatory Bowel Disease
Cited by 83
- Verified
The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts
Hov, J., & Karlsen, T. (2017) · Seminars in Liver Disease
Liver Diseases and ImmunityGut microbiota and health
Cited by 65
- Verified
Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis
Chung, B. K., Guevel, B. T., Reynolds, G. M., Gupta Udatha, D. B. R. K., Henriksen, E. K. K., Stamataki, Z., Hirschfield, G. M., Karlsen, T. H., & Liaskou, E. (2017) · Journal of Autoimmunity
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 57
- Verified
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease
Næss, S., Björnsson, E., Anmarkrud, J. A., Mamari, S. A., Juran, B. D., Lazaridis, K. N., Chapman, R., Bergquist, A., Melum, E., Marsh, S. G. E., et al. (2014) · Liver International
Liver Diseases and ImmunityInflammatory Bowel Disease
Cited by 54
- Verified
Clinical practice guidelines of the European association for the study of the liver - advancing methodology but preserving practicability
Cornberg, M., Tacke, F., & Karlsen, T. H. (2019) · Journal of Hepatology
Clinical practice guidelines implementationHepatitis C virus research
Cited by 49
- Verified
Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway
Andersen, I. M., Fosby, B., Boberg, K. M., Clausen, O. P. F., Jebsen, P., Melum, E., Line, P. D., Foss, A., Schrumpf, E., & Karlsen, T. H. (2015) · Transplantation Direct
Liver Diseases and ImmunityOrgan Transplantation Techniques and Outcomes
Cited by 45
- Verified
Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades
Nordin, A., Åberg, F., Pukkala, E., Pedersen, C. R., Storm, H. H., Rasmussen, A., Bennet, W., Olausson, M., Wilczek, H., Ericzon, B.-G., et al. (2018) · American Journal of Transplantation
Organ Transplantation Techniques and OutcomesViral-associated cancers and disorders
Cited by 45
- Verified
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis
Pollheimer, M. J., Racedo, S., Mikels-Vigdal, A., Marshall, D., Bowlus, C., Lackner, C., Madl, T., Karlsen, T. H., Hov, J. R., Lyman, S. K., et al. (2018) · Journal of Hepatology
Liver Diseases and ImmunityLiver physiology and pathology
Cited by 38
- Verified
Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients
Frank, A. K., Chung, B. K., De Novales, M. L. L., Engesæter, L. K., Hoyle, H. W., Øgaard, J., Heslop, J., Karlsen, T. H., Tysoe, O., Brevini, T., et al. (2024) · Digestive Diseases and Sciences
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 14
- Verified
The 6 C's of primary sclerosing cholangitis
Deeb, M., Karlsen, T. H., & Hirschfield, G. M. (2020) · Journal of Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 5
- Verified
OS-076-YI Bile extracellular vesicles hold protein biomarkers for the early diagnosis of cholangiocarcinoma in individuals with primary sclerosing cholangitis
Lapitz, A., Grimsrud, M., Rodrigues, P. M., Hov, J. R., Vesterhus, M., Azkargorta, M., Grzyb, K., Reims, H. M., Elortza, F., Izquierdo-Sánchez, L., et al. (2024) · Journal of Hepatology
Extracellular vesicles in diseaseCholangiocarcinoma and Gallbladder Cancer Studies
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free